|
DET1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86728410511705E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.06530007037975E-10 |
| Normal-vs-Stage3 |
1.63835611743934E-12 |
| Normal-vs-Stage4 |
1.63624669369256E-12 |
| Stage1-vs-Stage2 |
9.593000E-01 |
| Stage1-vs-Stage3 |
5.559700E-02 |
| Stage1-vs-Stage4 |
2.825700E-02 |
| Stage2-vs-Stage3 |
1.453040E-01 |
| Stage2-vs-Stage4 |
9.503800E-02 |
| Stage3-vs-Stage4 |
8.139200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.31189999999604E-06 |
| Normal-vs-Asian |
9.76274616704131E-12 |
| Caucasian-vs-AfricanAmerican |
5.071200E-01 |
| Caucasian-vs-Asian |
8.406200E-01 |
| AfricanAmerican-vs-Asian |
6.611600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33066907387547E-16 |
| Normal-vs-Female |
3.77142761465166E-13 |
| Male-vs-Female |
4.970800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62714286489063E-12 |
| Normal-vs-Age(81-100Yrs) |
8.90660000196775E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.539800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.984600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.628200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.031400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.858400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.744800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.580800E-04 |
| Classical-VS-Follicular |
6.007200E-01 |
| Classical-VS-Other |
7.102000E-01 |
| Classical-VS-Normal |
6.06004135761395E-12 |
| Tall-VS-Follicular |
5.808000E-04 |
| Tall-VS-Other |
3.426800E-01 |
| Tall-VS-Normal |
9.99200722162641E-16 |
| Follicular-VS-Other |
7.717800E-01 |
| Follicular-VS-Normal |
1.02389985379148E-10 |
| Other-VS-Normal |
1.421250E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
6.66133814775094E-16 |
| N0-vs-N1 |
2.876900E-03 |
|
|
